BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC
84 results:

  • 1. Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
    Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
    Tu J; Xu JZ; Zhang YS; Deng LF
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
    Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
    Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. mlh1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
    Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
    Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.
    Sukhanova M; Obeidin F; Streich L; Alexiev BA
    Genes Chromosomes Cancer; 2022 Nov; 61(11):653-661. PubMed ID: 35655404
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
    Kobayashi Y; Kitazono I; Akahane T; Yanazume S; Kamio M; Togami S; Nohara S; Sakamoto I; Yokoyama S; Tabata K; Kobayashi H; Tanimoto A
    Pathol Oncol Res; 2021; 27():1610013. PubMed ID: 35002543
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
    AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
    Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.
    Rah B; Banday MA; Bhat GR; Shah OJ; Jeelani H; Kawoosa F; Yousuf T; Afroze D
    World J Gastroenterol; 2021 Sep; 27(36):6093-6109. PubMed ID: 34629822
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy.
    Repetto M; Conforti F; Pirola S; Calvello M; Pala L; Bonanni B; Catania C; Curigliano G; De Pas T
    Eur J Cancer; 2021 Aug; 153():162-167. PubMed ID: 34161910
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mismatch repair deficiency is rare in bone and soft tissue tumors.
    Lam SW; Kostine M; de Miranda NFCC; Schöffski P; Lee CJ; Morreau H; Bovée JVMG
    Histopathology; 2021 Oct; 79(4):509-520. PubMed ID: 33825202
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
    Kang EY; Tessier-Cloutier B; Duggan MA; Stewart CJR; Lee CH; Köbel M
    Histopathology; 2021 Aug; 79(2):160-167. PubMed ID: 33432679
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions.
    Singh H; Li YY; Spurr LF; Shinagare AB; Abhyankar R; Reilly E; Brais LK; Nag A; Ducar MD; Thorner AR; Shapiro GI; Keller RB; Siletti C; Clark JW; Farago AF; Lin JJ; Demetri GD; Gujrathi R; Kulke MH; MacConaill LE; Ligon AH; Sicinska E; Meyerson ML; Meyerhardt JA; Cherniack AD; Wolpin BM; Ng K; Giannakis M; Hornick JL; Cleary JM
    Clin Cancer Res; 2021 Mar; 27(6):1695-1705. PubMed ID: 33414136
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I.
    Ishihara S; Yamada Y; Iwasaki T; Yoshimoto M; Toda Y; Kohashi K; Yamamoto H; Matsumoto Y; Nakashima Y; Oda Y
    Oncol Rep; 2021 Jan; 45(1):379-389. PubMed ID: 33155664
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
    Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
    Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA.
    Jeon HM; Lee JS; Kim SH; Yun KH; Park KH; Jeon MK; Lee YH; Yoon HI; Suh JS; Hur H; Kim KS; Kim S; Kim SH; Kim HS
    Oncology; 2020; 98(11):817-826. PubMed ID: 32892196
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.
    Segura SE; Pedra Nobre S; Hussein YR; Abu-Rustum NR; Weigelt B; Soslow RA; DeLair DF
    Am J Surg Pathol; 2020 Nov; 44(11):1573-1579. PubMed ID: 32804882
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Multi-institution Retrospective Review.
    Jenkins TM; Hanley KZ; Schwartz LE; Cantrell LA; Stoler MH; Mills AM
    Am J Surg Pathol; 2020 Jun; 44(6):782-792. PubMed ID: 31934920
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients.
    Arakawa K; Hata K; Nozawa H; Kawai K; Tanaka T; Nishikawa T; Sasaki K; Shuno Y; Kaneko M; Hiyoshi M; Emoto S; Murono K; Sonoda H; Okada S; Ishihara S
    Anticancer Res; 2019 Mar; 39(3):1425-1432. PubMed ID: 30842178
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.